A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.

Saved in:
Bibliographic Details
Title: A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.
Authors: Ertesvåg NU; Influenza Centre, University of Bergen, Bergen, Norway., Xiao J; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK., Zhou F; Influenza Centre, University of Bergen, Bergen, Norway., Ljostveit S; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Sandnes H; Department of Clinical Science, University of Bergen, Bergen, Norway., Lartey S; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway., Sævik M; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Hansen L; Influenza Centre, University of Bergen, Bergen, Norway., Madsen A; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway., Mohn KGI; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Fjelltveit E; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway., Olofsson JS; Influenza Centre, University of Bergen, Bergen, Norway., Tan TK; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK., Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK., Schimanski L; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK., Øyen S; Eidsvåg Family Practice, Bergen, Norway., Brokstad KA; Broegelmann Research Laboratory, University of Bergen, Bergen, Norway.; Department of Safety, Chemistry and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway., Dunachie S; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Jämsén A; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., James WS; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE UK., Harding AC; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE UK., Harvala H; Microbiology Services, NHS Blood and Transplant, Colindale, UK., Nguyen D; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Roberts D; Clinical, Research and Development, NHS Blood and Transplant, Oxford, UK., Zambon M; Virology Reference Department, National Infection Service, Public Health England, Colindale, UK., Townsend A; MRC Human Immunology Unit, MRC Weatherall Institute, John Radcliffe Hospital, Oxford, UK., Langeland N; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Haukeland University Hospital, Bergen, Norway.; National Advisory Unit for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway., Cox RJ; Influenza Centre, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Corporate Authors: PHE Virology group, Oxford collaborative group, Bergen COVID-19 Research Group
Source: Communications medicine [Commun Med (Lond)] 2022 Apr 05; Vol. 2, pp. 36. Date of Electronic Publication: 2022 Apr 05 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2730-664X
DOI:10.1038/s43856-022-00091-x